title: Toward a meningitis-free world.
abstract: Meningococcal meningitis is a devastating disease that is often fatal. Vaccines against the five major meningococcal serogroups causing disease are about to become available, a conjugate vaccine against meningococcus A is in use for mass vaccination in Africa, and a protein-based vaccine against meningococcal B is ready for licensure. With the availability of these new vaccines, the world can finally be rid of meningococcal meningitis, thus rewriting a new chapter in medical history.
authors.affiliation: Center for Global Health, Cincinnati Children's Hospital, Cincinnati, OH 45326, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Black
authors.forename: Mariagrazia
authors.initials: M
authors.lastname: Pizza
authors.forename: Mikkel
authors.initials: M
authors.lastname: Nissum
authors.forename: Rino
authors.initials: R
authors.lastname: Rappuoli
mesh_terms: D003226:Congresses as Topic; D003906:Developing Countries; D060740:Disease Eradication; D015195:Drug Design; D014943:Global Health; D006297:Health Services Accessibility; D006801:Humans; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology / Q000627:therapeutic use*; D009313:National Health Programs; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology* / Q000472:pathogenicity
chemical_list: D022401:Meningococcal Vaccines